Cure chronic and
‍aging-related diseases

Turning the physics of aging into medicines
Partnerships include
PfizerChugai
Published in
Sciencenpg Nature Publishing Group

We are delivering on our vision by

decoding

the latent causal biology of disease through applying physics-first AI to longitudinal human health data

designing

generative AI platforms to support these programmes

de-risking

clinical trials through improved target selection

drugging

drivers of chronic and aging-related diseases as well as aging itself

delivering

medicines to patients through both an internal and partnered drug discovery pipeline model

The approach

Our discovery platforms

We have developed Nidana to identify novel disease causal targets and ProtoBind to enable their drugging
NIDANA

Foundation Model of Human Diseases

Abstract illustration of diverse human profiles connected to a glowing central brain-like network, with organs, cells, molecules, and data streams.

Foundation Model of Human Diseases

Nidana is a physics-first AI model trained on ~250 million longitudinal patient medical data points across 400 diseases, modeling how disease evolves over time-revealing true causal pathways driving disease progression  

PROTOBIND

Sequence-Based Generative Chemistry

Abstract illustration of glowing molecular networks and DNA-like strands flowing through a radiant central sphere toward clustered molecules.

Sequence-Based Generative Chemistry

Trained on 3 million ligand-protein assay data points, ProtoBind generates and prioritizes drug-like small-molecules for challenging targets without requiring a 3D protein structure or known ligands, achieving wet-lab-validated hit rates of up to 25%

Stay tuned